Protagenic Therapeutics, Inc. (PTIX) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 2.3M | 2.86M | 4.33M | 928.18K | 1.88M | 1.42M | 1.37M | 2.47M | 4.2M | 5.38M | 6.92M | 7.66M |
| Cash & Short-Term Investments | 2.21M | 2.72M | 4.1M | 872.96K | 1.84M | 1.06M | 924.6K | 2.42M | 4.06M | 5.27M | 6.04M | 7.65M |
| Cash Only | 2.21M | 2.72M | 4.1M | 872.96K | 1.84M | 1.06M | 924.6K | 831.78K | 1.29M | 153.33K | 219.44K | 138.49K |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.59M | 2.77M | 5.12M | 5.82M | 7.51M |
| Accounts Receivable | 41.52K | 44.04K | 98.63K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 1.07K | 1.07K | 1.09K | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | 7.94 | 7.93 | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Non-Current Assets | -166.97K | -713.58K | 2.16M | 60.47K | 73.05K | 85.62K | 98.19K | 110.76K | 123.33K | 55.98K | 1.59K | 1.69K |
| Property, Plant & Equipment | 38.84K | 51.41K | 63.98K | 60.47K | 73.05K | 85.62K | 98.19K | 110.76K | 123.33K | 55.98K | 1.59K | 1.69K |
| Fixed Asset Turnover | - | - | - | - | -0.32x | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.09M | 2.09M | 2.09M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | -2.3M | -2.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Assets | 2.13M | 2.14M | 6.49M | 988.65K | 1.96M | 1.51M | 1.47M | 2.58M | 4.32M | 5.43M | 6.92M | 7.67M |
| Asset Turnover | - | - | - | - | -0.01x | - | - | - | - | - | - | - |
| Asset Growth % | 9.01% | 42.19% | 342.25% | -61.66% | -54.76% | -72.24% | -78.8% | -66.36% | -46.21% | -34.18% | -23.24% | -21.76% |
| Total Current Liabilities | 6.82M | 9.7M | 10.46M | 1.08M | 942.76K | 789.32K | 674.56K | 446.1K | 655.25K | 1.28M | 1.51M | 1.25M |
| Accounts Payable | 2.03M | 1.64M | 2.08M | 165.25K | 102.96K | 108.64K | 93.46K | 108.95K | 113.8K | 243.52K | 158.17K | 174.87K |
| Days Payables Outstanding | - | 13.63K | 8.14K | 960.02 | 387.12 | 739.5 | 732.6 | 806.17 | 617.51 | 13.02K | 166.52K | - |
| Short-Term Debt | 3.16M | 3.16M | 4.01M | 0 | 0 | 0 | 0 | 0 | 0 | 419.76K | 394.31K | 369.13K |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 1.64M | 4.91M | 3.86M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Ratio | 0.34x | 0.29x | 0.41x | 0.86x | 2.00x | 1.80x | 2.03x | 5.53x | 6.41x | 4.20x | 4.60x | 6.12x |
| Quick Ratio | 0.34x | 0.29x | 0.41x | 0.86x | 2.00x | 1.80x | 2.03x | 5.53x | 6.41x | 4.20x | 4.60x | 6.12x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Liabilities | 6.82M | 9.7M | 10.46M | 1.08M | 942.76K | 789.32K | 674.56K | 446.1K | 655.25K | 1.28M | 1.51M | 1.25M |
| Total Debt | 3.16M | 3.16M | 4.01M | 0 | 0 | 0 | 0 | 0 | 0 | 419.76K | 394.31K | 369.13K |
| Net Debt | 943.26K | 433.6K | -83.18K | -872.96K | -1.84M | -1.06M | -924.6K | -831.78K | -1.29M | 266.43K | 174.87K | 230.64K |
| Debt / Equity | - | - | - | - | - | - | - | - | - | 0.10x | 0.07x | 0.06x |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | - | -25.32x | -20.19x | - | - | - | - | - | -127.76x | -42.71x | -37.27x | -21.97x |
| Total Equity | -4.69M | -7.56M | -3.97M | -88.33K | 1.01M | 719.01K | 792.52K | 2.13M | 3.67M | 4.15M | 5.41M | 6.41M |
| Equity Growth % | -563.08% | -1151.28% | -601.44% | -104.14% | -72.38% | -82.69% | -85.36% | -66.75% | -46.97% | -43.75% | -34.44% | -26.44% |
| Book Value per Share | -2.42 | -4.09 | -1.07 | -0.17 | 0.16 | 0.16 | 0.18 | 0.48 | 0.84 | 0.96 | 1.25 | 1.49 |
| Total Shareholders' Equity | -2.39M | -4.7M | -3.97M | -88.33K | 1.01M | 719.01K | 792.52K | 2.13M | 3.67M | 4.15M | 5.41M | 6.41M |
| Common Stock | 195 | 195 | 186 | 54 | 725 | 481 | 447 | 444 | 444 | 434 | 434 | 434 |
| Retained Earnings | -9.11M | -11.32M | -10.46M | -37.74M | -36.3M | -34.75M | -34.11M | -32.5M | -30.78M | -29.1M | -27.71M | -26.5M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | -220.01K | -221.17K | -258.24K | -129.86K | -129.85K | -130.25K | -130.16K | -86.77K | -113.55K | -617.74K | -586.46K | -628.76K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |